Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
Naghavian R, et al.
Nature
October 2023
Authors and Affiliates
Reza Naghavian 1,2, Wolfgang Faigle 1,2,3, Pietro Oldrati 1, Jian Wang 1,4, Nora C Toussaint 5,6, Yuhan Qiu 1, Gioele Medici 7, Marcel Wacker 8,9,10,11, Lena K Freudenmann 9,10,11, Pierre-Emmanuel Bonté 3, Michael Weller 12, Luca Regli 7, Sebastian Amigorena 3, Hans-Georg Rammensee 9,10,11, Juliane S Walz 8,9,10,11,13, Silvio D Brugger 14, Malte Mohme 15, Yingdong Zhao 16, Mireia Sospedra 1,2, Marian C Neidert 7,17, Roland Martin 18,19,20,21;
1 Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
2 Cellerys AG, Schlieren, Switzerland.
3 Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France.
4 School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
5 NEXUS Personalized Health Technologies, ETH Zurich, Schlieren, Switzerland.
6 Swiss Institute of Bioinformatics, Zurich, Switzerland.
7 Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
8 Department of Peptide-based Immunotherapy, University of Tübingen, University Hospital Tübingen, Tübingen, Germany.
9 Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
10 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.
11 Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
12 Laboratory of Molecular Neuro-Oncology, Department of Neurology and Clinical Neuroscience, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
13 Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
14 Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
15 Department of Neurosurgery, University Hospital Hamburg Eppendorf, University of Hamburg, Hamburg, Germany.
16 Computational and Systems Biology Branch, Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA.
17 Department of Neurosurgery, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
18 Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland. roland.martin@uzh.ch.
19 Cellerys AG, Schlieren, Switzerland. roland.martin@uzh.ch.
20 Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. roland.martin@uzh.ch.
21 Therapeutic Immune Design Unit, Center for Molecular Medicine, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden. roland.martin@uzh.ch.